Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. (Q44587948)
Jump to navigation
Jump to search
scientific article published in September 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer. |
scientific article published in September 2003 |
Statements
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer (English)
Silke Westphalen
Wei Hu
Evelyne Loyer
Andrzej Kudelka
Peter Völker
John Kavanagh
Melissa Steger
Klaus-Dieter Schulz
1 September 2003